Teresa Victoria, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prenatal Diagnosis | 39 | 2024 | 1268 | 5.330 |
Why?
|
| Bone Diseases, Developmental | 5 | 2023 | 131 | 2.560 |
Why?
|
| Fetus | 13 | 2023 | 1870 | 2.450 |
Why?
|
| Lymphangiectasis | 4 | 2021 | 20 | 1.870 |
Why?
|
| Magnetic Resonance Imaging | 48 | 2024 | 36532 | 1.820 |
Why?
|
| Ultrasonography, Prenatal | 17 | 2024 | 1774 | 1.740 |
Why?
|
| Hernia, Umbilical | 4 | 2021 | 102 | 1.690 |
Why?
|
| Respiratory System Abnormalities | 3 | 2020 | 67 | 1.310 |
Why?
|
| Lung | 13 | 2023 | 10033 | 1.240 |
Why?
|
| Fetal Diseases | 6 | 2024 | 914 | 0.970 |
Why?
|
| Abdominal Wall | 2 | 2018 | 166 | 0.940 |
Why?
|
| Lung Volume Measurements | 5 | 2023 | 381 | 0.940 |
Why?
|
| Pregnancy | 42 | 2024 | 30260 | 0.890 |
Why?
|
| Anus, Imperforate | 1 | 2020 | 63 | 0.680 |
Why?
|
| Anthropometry | 1 | 2024 | 1338 | 0.670 |
Why?
|
| Radiology | 3 | 2024 | 2090 | 0.670 |
Why?
|
| Urogenital Abnormalities | 3 | 2018 | 255 | 0.640 |
Why?
|
| Bladder Exstrophy | 1 | 2020 | 107 | 0.630 |
Why?
|
| Radiation Protection | 2 | 2013 | 424 | 0.620 |
Why?
|
| Physicians, Women | 1 | 2024 | 512 | 0.610 |
Why?
|
| Image Enhancement | 5 | 2020 | 2858 | 0.590 |
Why?
|
| Digestive System Abnormalities | 1 | 2018 | 49 | 0.580 |
Why?
|
| Lung Diseases | 4 | 2015 | 1940 | 0.560 |
Why?
|
| Gestational Age | 9 | 2024 | 3609 | 0.550 |
Why?
|
| Amniotic Fluid | 1 | 2019 | 380 | 0.550 |
Why?
|
| Hearing Loss, Noise-Induced | 1 | 2018 | 144 | 0.540 |
Why?
|
| Balloon Occlusion | 1 | 2017 | 129 | 0.540 |
Why?
|
| Fetoscopy | 1 | 2017 | 140 | 0.520 |
Why?
|
| Bone and Bones | 2 | 2016 | 2554 | 0.450 |
Why?
|
| Neonatal Screening | 1 | 2018 | 627 | 0.440 |
Why?
|
| Movement | 1 | 2020 | 1462 | 0.430 |
Why?
|
| Limb Deformities, Congenital | 1 | 2014 | 136 | 0.420 |
Why?
|
| Infant, Newborn | 21 | 2024 | 26346 | 0.410 |
Why?
|
| Bone Development | 1 | 2016 | 468 | 0.410 |
Why?
|
| Orchidaceae | 1 | 2011 | 3 | 0.390 |
Why?
|
| Cystic Adenomatoid Malformation of Lung, Congenital | 2 | 2023 | 42 | 0.390 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2023 | 20659 | 0.380 |
Why?
|
| Carbon Tetrachloride | 1 | 2011 | 73 | 0.380 |
Why?
|
| Body Burden | 1 | 2012 | 156 | 0.380 |
Why?
|
| Trachea | 1 | 2017 | 1085 | 0.370 |
Why?
|
| Lymphatic Abnormalities | 3 | 2019 | 134 | 0.370 |
Why?
|
| Female | 55 | 2024 | 396112 | 0.360 |
Why?
|
| Protective Agents | 1 | 2011 | 151 | 0.350 |
Why?
|
| Diatrizoate Meglumine | 1 | 2010 | 80 | 0.350 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2015 | 595 | 0.340 |
Why?
|
| Fetal Death | 2 | 2014 | 435 | 0.340 |
Why?
|
| Whole Body Imaging | 1 | 2012 | 281 | 0.330 |
Why?
|
| Barium Sulfate | 1 | 2010 | 180 | 0.330 |
Why?
|
| Liver | 4 | 2017 | 7562 | 0.330 |
Why?
|
| Abnormalities, Multiple | 2 | 2014 | 1424 | 0.320 |
Why?
|
| Appendix | 1 | 2010 | 109 | 0.320 |
Why?
|
| Flavonoids | 1 | 2011 | 448 | 0.300 |
Why?
|
| Plant Extracts | 1 | 2011 | 496 | 0.290 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2008 | 101 | 0.290 |
Why?
|
| Esophageal Diseases | 1 | 2009 | 166 | 0.290 |
Why?
|
| Humans | 76 | 2024 | 765968 | 0.290 |
Why?
|
| Stomach | 1 | 2012 | 699 | 0.290 |
Why?
|
| Lymphatic Diseases | 2 | 2020 | 317 | 0.290 |
Why?
|
| Biliary Tract Diseases | 1 | 2008 | 160 | 0.280 |
Why?
|
| Retrospective Studies | 20 | 2024 | 81514 | 0.280 |
Why?
|
| Galactosylceramidase | 5 | 1999 | 22 | 0.280 |
Why?
|
| Radiation Dosage | 2 | 2013 | 1944 | 0.270 |
Why?
|
| Contrast Media | 5 | 2021 | 5329 | 0.260 |
Why?
|
| Leukodystrophy, Globoid Cell | 6 | 1999 | 38 | 0.260 |
Why?
|
| Pancreatic Diseases | 1 | 2008 | 353 | 0.260 |
Why?
|
| Oculocerebrorenal Syndrome | 1 | 2024 | 10 | 0.230 |
Why?
|
| Lymphography | 3 | 2020 | 189 | 0.220 |
Why?
|
| Child | 17 | 2023 | 80564 | 0.210 |
Why?
|
| Organ Size | 3 | 2013 | 2260 | 0.200 |
Why?
|
| Foot Diseases | 1 | 2023 | 147 | 0.200 |
Why?
|
| Placenta | 1 | 2011 | 1728 | 0.200 |
Why?
|
| Dog Diseases | 3 | 1999 | 142 | 0.200 |
Why?
|
| Infant | 10 | 2023 | 36386 | 0.190 |
Why?
|
| Hernia, Diaphragmatic | 2 | 2013 | 243 | 0.190 |
Why?
|
| Diagnosis, Differential | 9 | 2023 | 12976 | 0.190 |
Why?
|
| Nephrogenic Fibrosing Dermopathy | 1 | 2021 | 42 | 0.180 |
Why?
|
| Bronchopulmonary Sequestration | 1 | 2020 | 43 | 0.180 |
Why?
|
| Fetal Growth Retardation | 1 | 2024 | 591 | 0.180 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2021 | 74 | 0.170 |
Why?
|
| Pregnancy Outcome | 4 | 2021 | 2966 | 0.170 |
Why?
|
| Exodeoxyribonucleases | 1 | 2021 | 191 | 0.170 |
Why?
|
| Nephroma, Mesoblastic | 1 | 2020 | 25 | 0.170 |
Why?
|
| Proteinuria | 1 | 2023 | 607 | 0.170 |
Why?
|
| Choledochal Cyst | 1 | 2020 | 25 | 0.170 |
Why?
|
| Sacrococcygeal Region | 1 | 2020 | 52 | 0.170 |
Why?
|
| Rhabdomyoma | 1 | 2020 | 56 | 0.160 |
Why?
|
| Nomograms | 1 | 2021 | 235 | 0.160 |
Why?
|
| Nervous System Malformations | 1 | 2021 | 243 | 0.160 |
Why?
|
| Ovarian Cysts | 1 | 2020 | 106 | 0.160 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2023 | 1480 | 0.160 |
Why?
|
| Musculoskeletal System | 1 | 2020 | 187 | 0.150 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2020 | 869 | 0.150 |
Why?
|
| Noonan Syndrome | 1 | 2019 | 122 | 0.150 |
Why?
|
| Ultrasonography | 3 | 2023 | 5993 | 0.150 |
Why?
|
| Hearing Tests | 1 | 2018 | 123 | 0.150 |
Why?
|
| Fibrosarcoma | 1 | 2020 | 313 | 0.150 |
Why?
|
| Cataract | 1 | 2024 | 837 | 0.150 |
Why?
|
| Prognosis | 7 | 2021 | 29922 | 0.140 |
Why?
|
| Acoustics | 1 | 2018 | 235 | 0.140 |
Why?
|
| Gastroschisis | 1 | 2018 | 99 | 0.140 |
Why?
|
| Male | 21 | 2024 | 363698 | 0.140 |
Why?
|
| Takayasu Arteritis | 1 | 2018 | 104 | 0.140 |
Why?
|
| Teratoma | 1 | 2020 | 401 | 0.130 |
Why?
|
| Anesthetics | 1 | 2022 | 525 | 0.130 |
Why?
|
| Reference Values | 2 | 2016 | 4908 | 0.130 |
Why?
|
| Philadelphia | 1 | 2017 | 267 | 0.130 |
Why?
|
| Lymphatic Vessels | 1 | 2020 | 355 | 0.130 |
Why?
|
| Birth Weight | 1 | 2024 | 2121 | 0.130 |
Why?
|
| Faculty, Medical | 1 | 2024 | 1219 | 0.130 |
Why?
|
| Fetal Mortality | 1 | 2015 | 19 | 0.130 |
Why?
|
| Heart Neoplasms | 1 | 2020 | 375 | 0.130 |
Why?
|
| Respiratory Insufficiency | 2 | 2023 | 1240 | 0.130 |
Why?
|
| Fever | 1 | 2023 | 1603 | 0.130 |
Why?
|
| Heart Diseases | 1 | 2009 | 2821 | 0.130 |
Why?
|
| Myositis Ossificans | 1 | 2016 | 76 | 0.120 |
Why?
|
| Cephalometry | 1 | 2017 | 380 | 0.120 |
Why?
|
| Congenital Abnormalities | 2 | 2010 | 704 | 0.120 |
Why?
|
| Dyspnea | 1 | 2023 | 1352 | 0.120 |
Why?
|
| Pulmonary Embolism | 1 | 2008 | 2598 | 0.120 |
Why?
|
| Calcaneus | 1 | 2016 | 144 | 0.120 |
Why?
|
| Hemangioma | 1 | 2020 | 723 | 0.120 |
Why?
|
| Uterine Diseases | 1 | 2015 | 108 | 0.120 |
Why?
|
| Pennsylvania | 1 | 2015 | 614 | 0.110 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2020 | 730 | 0.110 |
Why?
|
| Academic Medical Centers | 1 | 2024 | 2780 | 0.110 |
Why?
|
| Dogs | 4 | 1999 | 3822 | 0.110 |
Why?
|
| Reproducibility of Results | 4 | 2019 | 20124 | 0.110 |
Why?
|
| Echoencephalography | 1 | 2014 | 133 | 0.110 |
Why?
|
| Pregnancy, Multiple | 1 | 2014 | 216 | 0.110 |
Why?
|
| Hodgkin Disease | 1 | 2021 | 1383 | 0.110 |
Why?
|
| Range of Motion, Articular | 1 | 2020 | 1594 | 0.110 |
Why?
|
| Diagnostic Imaging | 3 | 2013 | 3529 | 0.110 |
Why?
|
| Inguinal Canal | 1 | 2013 | 71 | 0.110 |
Why?
|
| Pulmonary Emphysema | 1 | 2018 | 683 | 0.100 |
Why?
|
| Placenta Diseases | 1 | 2015 | 199 | 0.100 |
Why?
|
| Appendicitis | 1 | 2019 | 679 | 0.100 |
Why?
|
| Leadership | 1 | 2022 | 1392 | 0.100 |
Why?
|
| Artifacts | 2 | 2014 | 1893 | 0.100 |
Why?
|
| Phosphoproteins | 1 | 2021 | 2446 | 0.100 |
Why?
|
| Chromatography | 1 | 2011 | 187 | 0.100 |
Why?
|
| Silymarin | 1 | 2011 | 43 | 0.090 |
Why?
|
| Sensitivity and Specificity | 4 | 2019 | 14652 | 0.090 |
Why?
|
| Neuroblastoma | 1 | 2020 | 1263 | 0.090 |
Why?
|
| Methanol | 1 | 2011 | 90 | 0.090 |
Why?
|
| Young Adult | 7 | 2023 | 59889 | 0.090 |
Why?
|
| Plant Roots | 1 | 2011 | 121 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2021 | 3672 | 0.090 |
Why?
|
| Child, Preschool | 8 | 2019 | 42500 | 0.090 |
Why?
|
| Anesthesia | 1 | 2022 | 1590 | 0.090 |
Why?
|
| Plants, Medicinal | 1 | 2011 | 166 | 0.090 |
Why?
|
| Cytoprotection | 1 | 2011 | 200 | 0.090 |
Why?
|
| Point Mutation | 1 | 1996 | 1590 | 0.090 |
Why?
|
| Neoplasms | 1 | 2020 | 22340 | 0.090 |
Why?
|
| Adult | 11 | 2024 | 223044 | 0.090 |
Why?
|
| Phantoms, Imaging | 1 | 2019 | 2475 | 0.090 |
Why?
|
| Bronchi | 1 | 2014 | 843 | 0.090 |
Why?
|
| Fetal Development | 1 | 2016 | 777 | 0.090 |
Why?
|
| Solvents | 1 | 2011 | 299 | 0.090 |
Why?
|
| Prenatal Care | 1 | 2017 | 1160 | 0.080 |
Why?
|
| Postnatal Care | 1 | 2012 | 275 | 0.080 |
Why?
|
| Causality | 1 | 2015 | 1248 | 0.080 |
Why?
|
| Clubfoot | 1 | 2010 | 87 | 0.080 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2014 | 587 | 0.080 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2011 | 587 | 0.080 |
Why?
|
| Genital Diseases, Female | 1 | 2010 | 193 | 0.080 |
Why?
|
| Esophagus | 1 | 2014 | 1037 | 0.080 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2011 | 737 | 0.080 |
Why?
|
| Meningomyelocele | 1 | 2010 | 182 | 0.080 |
Why?
|
| Pain | 1 | 2023 | 5077 | 0.070 |
Why?
|
| Maternal Age | 1 | 2011 | 804 | 0.070 |
Why?
|
| False Negative Reactions | 1 | 2008 | 573 | 0.070 |
Why?
|
| Molecular Structure | 1 | 2011 | 1885 | 0.070 |
Why?
|
| Adolescent | 7 | 2023 | 88835 | 0.070 |
Why?
|
| Communication | 1 | 2021 | 3916 | 0.070 |
Why?
|
| Reference Standards | 1 | 2010 | 1013 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2009 | 15747 | 0.070 |
Why?
|
| Phenotype | 1 | 2024 | 16721 | 0.060 |
Why?
|
| Brain Diseases | 1 | 2014 | 1546 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2016 | 3356 | 0.060 |
Why?
|
| DNA, Complementary | 3 | 1997 | 1984 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2016 | 5302 | 0.060 |
Why?
|
| Risk Factors | 4 | 2019 | 74840 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 4353 | 0.060 |
Why?
|
| Kidney Neoplasms | 1 | 2020 | 4274 | 0.050 |
Why?
|
| Conscious Sedation | 2 | 2022 | 531 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2010 | 4015 | 0.050 |
Why?
|
| Radiography, Thoracic | 1 | 2008 | 1315 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2024 | 416 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2011 | 22223 | 0.050 |
Why?
|
| Survival Rate | 1 | 2015 | 12795 | 0.050 |
Why?
|
| Surface Plasmon Resonance | 1 | 2022 | 268 | 0.050 |
Why?
|
| Comorbidity | 1 | 2015 | 10563 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 15398 | 0.040 |
Why?
|
| Foot | 1 | 2023 | 573 | 0.040 |
Why?
|
| Ethiodized Oil | 1 | 2019 | 27 | 0.040 |
Why?
|
| Injections, Intravenous | 1 | 2021 | 1377 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2012 | 8733 | 0.040 |
Why?
|
| Thoracic Duct | 1 | 2019 | 71 | 0.040 |
Why?
|
| Chylothorax | 1 | 2019 | 83 | 0.040 |
Why?
|
| Pregnancy Complications | 1 | 2011 | 2975 | 0.040 |
Why?
|
| Monkey Diseases | 1 | 1997 | 71 | 0.030 |
Why?
|
| Abdomen | 1 | 2023 | 1134 | 0.030 |
Why?
|
| Ascites | 1 | 2019 | 336 | 0.030 |
Why?
|
| Canada | 1 | 2022 | 2119 | 0.030 |
Why?
|
| Genetic Counseling | 1 | 2020 | 634 | 0.030 |
Why?
|
| Patient Selection | 1 | 2008 | 4255 | 0.030 |
Why?
|
| Gadolinium | 1 | 2021 | 965 | 0.030 |
Why?
|
| Appendectomy | 1 | 2019 | 444 | 0.030 |
Why?
|
| Pleural Effusion | 1 | 2019 | 346 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1996 | 848 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1997 | 2745 | 0.030 |
Why?
|
| Organometallic Compounds | 1 | 2019 | 644 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 13451 | 0.030 |
Why?
|
| Species Specificity | 2 | 1997 | 2406 | 0.030 |
Why?
|
| DNA Primers | 2 | 1997 | 2825 | 0.030 |
Why?
|
| Transfection | 3 | 1999 | 5743 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 2019 | 947 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2023 | 1217 | 0.030 |
Why?
|
| Middle Aged | 2 | 2020 | 223009 | 0.030 |
Why?
|
| Japan | 1 | 2018 | 1415 | 0.030 |
Why?
|
| Sclerotherapy | 1 | 2015 | 184 | 0.030 |
Why?
|
| Retroviridae | 1 | 1996 | 847 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2011 | 18293 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2016 | 41649 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2017 | 65188 | 0.030 |
Why?
|
| Glycosylation | 1 | 1996 | 1100 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 1996 | 820 | 0.030 |
Why?
|
| Axilla | 1 | 2015 | 615 | 0.030 |
Why?
|
| Prevalence | 1 | 2008 | 15842 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 1996 | 1216 | 0.020 |
Why?
|
| Mice | 4 | 2011 | 81819 | 0.020 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2014 | 361 | 0.020 |
Why?
|
| Intensive Care, Neonatal | 1 | 2012 | 200 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 1997 | 2341 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2019 | 1531 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2015 | 697 | 0.020 |
Why?
|
| Cysts | 1 | 2015 | 684 | 0.020 |
Why?
|
| Molecular Sequence Data | 3 | 1997 | 17594 | 0.020 |
Why?
|
| Airway Management | 1 | 2012 | 297 | 0.020 |
Why?
|
| Base Sequence | 2 | 1997 | 12403 | 0.020 |
Why?
|
| Infant, Premature, Diseases | 1 | 2014 | 713 | 0.020 |
Why?
|
| Hypotension | 1 | 2014 | 885 | 0.020 |
Why?
|
| Leukocytes | 1 | 1996 | 2027 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 1997 | 13400 | 0.020 |
Why?
|
| Animals | 6 | 2011 | 168764 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1996 | 6069 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 1996 | 3404 | 0.020 |
Why?
|
| Morbidity | 1 | 2012 | 1749 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 6493 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 1997 | 5786 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2010 | 1589 | 0.020 |
Why?
|
| Mutation | 3 | 2021 | 30198 | 0.020 |
Why?
|
| ROC Curve | 1 | 2014 | 3620 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2019 | 4034 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2018 | 12437 | 0.010 |
Why?
|
| Observer Variation | 1 | 2010 | 2615 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 8529 | 0.010 |
Why?
|
| Cell Line | 1 | 1996 | 15543 | 0.010 |
Why?
|
| Cloning, Molecular | 2 | 1997 | 4165 | 0.010 |
Why?
|
| Brain | 2 | 2014 | 27171 | 0.010 |
Why?
|
| Codon, Initiator | 1 | 1997 | 50 | 0.010 |
Why?
|
| Lysosomal Storage Diseases | 1 | 1997 | 80 | 0.010 |
Why?
|
| Fibroblasts | 2 | 1999 | 4159 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1999 | 952 | 0.010 |
Why?
|
| Evoked Potentials, Auditory | 1 | 1998 | 530 | 0.010 |
Why?
|
| Introns | 1 | 1997 | 966 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 39193 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 1996 | 898 | 0.010 |
Why?
|
| Brain Stem | 1 | 1998 | 853 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 1999 | 18973 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1997 | 3067 | 0.010 |
Why?
|
| Exons | 1 | 1997 | 2391 | 0.010 |
Why?
|
| Lysosomes | 1 | 1996 | 932 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 1997 | 4108 | 0.000 |
Why?
|
| Lipids | 1 | 1999 | 3315 | 0.000 |
Why?
|
| Sequence Analysis, DNA | 1 | 1997 | 4772 | 0.000 |
Why?
|
| Genotype | 1 | 1999 | 13024 | 0.000 |
Why?
|
| Electroencephalography | 1 | 1998 | 6273 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1996 | 12768 | 0.000 |
Why?
|
| Disease Progression | 1 | 1998 | 13632 | 0.000 |
Why?
|
| Rats | 1 | 1996 | 23707 | 0.000 |
Why?
|